Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chapman

Showing results (281-290 of 345) with videos related to

Pageof 35
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 29, 2024
The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic EncephalopathyGunes Sevinc, Kari Knox, Michelle George, et al.
American Journal of Public Health|December 8, 1998
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996D C Des Jarlais, T Perlis, S R Friedman, et al.
Connective Tissue Research|January 1, 1996
Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilageJ M Olszewski, V L Moore, J McDonnell, et al.
Epilepsy & Behavior : E&B|September 21, 2024
Novel approaches to measuring cognition in individuals with severe to profound functional impairment: A pilot study in SCN2A-related disorderNatasha N Ludwig, Mary Wojnaroski, Stacy J Suskauer, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptorsChristopher A Willoughby, Steven M Hutchins, Keith G Rosauer, et al.
Physical Review Letters|August 9, 2014
Probing the structure and dynamics of molecular clusters using rotational wave packetsGediminas Galinis, Cephise Cacho, Richard T Chapman, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituentJoseph L Duffy, Thomas A Rano, Nancy J Kevin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituentJoseph L Duffy, Brian A Kirk, Nancy J Kevin, et al.
Nano Letters|December 3, 2014
Tunable carrier multiplication and cooling in grapheneJens Christian Johannsen, Søren Ulstrup, Alberto Crepaldi, et al.
Pageof 35

Showing results (281-290 of 345) with videos related to

Sort By:
Pageof 35
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 29, 2024
The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic EncephalopathyGunes Sevinc, Kari Knox, Michelle George, et al.
American Journal of Public Health|December 8, 1998
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996D C Des Jarlais, T Perlis, S R Friedman, et al.
Connective Tissue Research|January 1, 1996
Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilageJ M Olszewski, V L Moore, J McDonnell, et al.
Epilepsy & Behavior : E&B|September 21, 2024
Novel approaches to measuring cognition in individuals with severe to profound functional impairment: A pilot study in SCN2A-related disorderNatasha N Ludwig, Mary Wojnaroski, Stacy J Suskauer, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptorsChristopher A Willoughby, Steven M Hutchins, Keith G Rosauer, et al.
Physical Review Letters|August 9, 2014
Probing the structure and dynamics of molecular clusters using rotational wave packetsGediminas Galinis, Cephise Cacho, Richard T Chapman, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituentJoseph L Duffy, Thomas A Rano, Nancy J Kevin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituentJoseph L Duffy, Brian A Kirk, Nancy J Kevin, et al.
Nano Letters|December 3, 2014
Tunable carrier multiplication and cooling in grapheneJens Christian Johannsen, Søren Ulstrup, Alberto Crepaldi, et al.
Pageof 35